Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedPublications description updated to 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the page revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedAdministrative funding status notice was removed from the page. The rest of the study details, eligibility criteria, and intervention descriptions remain unchanged.SummaryDifference0.3%

- Check49 days agoChange DetectedThe new screenshot shows minor formatting and wording adjustments across the page; core trial details, arms, outcomes, and listed locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange Detected- Added a government funding and operating-status notice and updated the version to v3.2.0. - Removed the specific resource topic “Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus” and downgraded the revision from v3.1.0 to v3.2.0.SummaryDifference3%

- Check77 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.